PKIB has been implicated in several different cancer types as a potential target for cancer therapy, including prostate, breast, lung, and colorectal cancers, which account for half of new cancer diagnoses and nearly half the number of cancer deaths each year [28]. The gene discussed is PKIB; the disease is cancer.